Nyberg, W., Bernard, P.-L., Ark, J., Ngo, W., Hamilton, J., Stickels, R., … Eyquem, J. (2025). In Vivo Generation of TRAC-Targeted CAR T Cells via Site-Specific Integration Enables Cell-Specific Engineering and Potent Antitumor Activity. In MOLECULAR THERAPY (Vol. 33).

Nyberg, William, Pierre-Louis Bernard, Jonathan Ark, Wayne Ngo, Jennifer Hamilton, Robert Stickels, Jennifer Doudna, Aravind Asokan, and Justin Eyquem. “In Vivo Generation of TRAC-Targeted CAR T Cells via Site-Specific Integration Enables Cell-Specific Engineering and Potent Antitumor Activity.” In MOLECULAR THERAPY, Vol. 33, 2025.

Nyberg W, Bernard P-L, Ark J, Ngo W, Hamilton J, Stickels R, et al. In Vivo Generation of TRAC-Targeted CAR T Cells via Site-Specific Integration Enables Cell-Specific Engineering and Potent Antitumor Activity. In: MOLECULAR THERAPY. 2025.

Nyberg, William, et al. “In Vivo Generation of TRAC-Targeted CAR T Cells via Site-Specific Integration Enables Cell-Specific Engineering and Potent Antitumor Activity.” MOLECULAR THERAPY, vol. 33, no. 4, 2025.

Nyberg W, Bernard P-L, Ark J, Ngo W, Hamilton J, Stickels R, Doudna J, Asokan A, Eyquem J. In Vivo Generation of TRAC-Targeted CAR T Cells via Site-Specific Integration Enables Cell-Specific Engineering and Potent Antitumor Activity. MOLECULAR THERAPY. 2025.